Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Source: oneinchpunch|Shutterstock.com We’re starting off Wednesday with a breakdown of the biggest pre-market stock movers for investors to keep an eye on! Moving stocks this morning is a ration change, clinical trial news, preliminary earnings data, and more. Let’s jump into that news below! Pre-Market Stock Movers: 10 Top Gainers SOS (NYSE: SOS ) stock is rocketing more than 4,408% due to a ratio change for its American depositary shares (ADS) . HEXO (NASDAQ: HEXO ) shares are soaring over 68% after investors approved a note transaction yesterday . SCWorx (NASDAQ: WORX ) stock is surging close to 37% after reaching a common stock purchase agreement with an institutional investor. Enjoy Technology (NASDAQ: ENJY ) shares are rising more than 27% on heavy trading following bankruptcy news . Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is gaining over 22% after providing an update for a Phase 2 clinical trial . Bright Green (NASDAQ: BGXX ) shares are climbing more than 18% in pre-market trading today.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Source: oneinchpunch|Shutterstock.com We’re starting off Wednesday with a breakdown of the biggest pre-market stock movers for investors to keep an eye on! Moving stocks this morning is a ration change, clinical trial news, preliminary earnings data, and more. Let’s jump into that news below! Pre-Market Stock Movers: 10 Top Gainers SOS (NYSE: SOS ) stock is rocketing more than 4,408% due to a ratio change for its American depositary shares (ADS) . HEXO (NASDAQ: HEXO ) shares are soaring over 68% after investors approved a note transaction yesterday . SCWorx (NASDAQ: WORX ) stock is surging close to 37% after reaching a common stock purchase agreement with an institutional investor. Enjoy Technology (NASDAQ: ENJY ) shares are rising more than 27% on heavy trading following bankruptcy news . Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is gaining over 22% after providing an update for a Phase 2 clinical trial . Bright Green (NASDAQ: BGXX ) shares are climbing more than 18% in pre-market trading today.